We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EA
401
DELISTED
Electronic Arts
EA
| $46M | 0.04% |
224,550
+104
| +0% | +$21.1K |
|
|
CRWV
402
PUT
CoreWeave
CRWV
$55.1B
| $46M | 0.04% |
+462,000
| New | +$49.9M |
|
403
Cavco Industries
CVCO
$4.21B
| $46M | 0.04% |
74,839
+67,999
| +994% | +$36.1M |
|
404
Praxis Precision Medicines
PRAX
$9.84B
| $45.9M | 0.04% |
137,008
+91,859
| +203% | +$29.1M |
|
405
Autodesk
ADSK
$44.4B
| $45.8M | 0.04% |
235,800
-10,529
| -4% | -$2.4M |
|
406
Revolution Medicines
RVMD
$44.4B
| $45.8M | 0.04% |
244,544
+27,883
| +13% | +$4.07M |
|
407
PUT
Thermo Fisher Scientific
TMO
$223B
| $45.7M | 0.04% |
91,200
+90,500
| +12,929% | +$43.4M |
|
408
GFL Environmental
GFL
$18.7B
| $45.7M | 0.04% |
1,242,546
-914,298
| -42% | -$34.6M |
|
409
Neurocrine Biosciences
NBIX
$15.8B
| $45.6M | 0.04% |
270,754
-238,223
| -47% | -$35.3M |
|
410
Cigna
CI
$72.9B
| $45.6M | 0.04% |
165,287
+108,107
| +189% | +$30.5M |
|
411
Exelixis
EXEL
$14.3B
| $45.2M | 0.04% |
831,506
+531,493
| +177% | +$25.9M |
|
412
S&P Global
SPGI
$127B
| $44.7M | 0.04% |
109,730
+87,647
| +397% | +$37M |
|
413
Modine Manufacturing
MOD
$10.2B
| $44.7M | 0.04% |
167,285
+92,127
| +123% | +$24.3M |
|
414
Acadia Pharmaceuticals
ACAD
$4.75B
| $44.7M | 0.04% |
1,764,838
+1,688,651
| +2,216% | +$37.2M |
|
415
Kenvue
KVUE
$35.3B
| $44.5M | 0.04% |
2,328,167
-11,820,394
| -84% | -$208M |
|
416
Matador Resources
MTDR
$7.4B
| $44.4M | 0.04% |
891,834
+766,253
| +610% | +$43.6M |
|
417
FIGS
FIGS
$2.27B
| $44.4M | 0.04% |
4,335,698
+1,119,236
| +35% | +$14.7M |
|
418
Howmet Aerospace
HWM
$92.3B
| $44.3M | 0.04% |
164,754
-130,636
| -44% | -$33.5M |
|
419
iShares Silver Trust
SLV
$32B
| $44.1M | 0.03% |
825,075
+430,398
| +109% | +$28.5M |
|
420
Glaukos
GKOS
$10.9B
| $44M | 0.03% |
314,804
+280,705
| +823% | +$35.5M |
|
421
Intuitive Surgical
ISRG
$124B
| $43.8M | 0.03% |
110,089
-209,908
| -66% | -$91.7M |
|
422
Fox Class B
FOX
$24.5B
| $43.7M | 0.03% |
933,541
+913,641
| +4,591% | +$50.8M |
|
423
Revolve Group
RVLV
$1.43B
| $43.6M | 0.03% |
1,904,833
-45,918
| -2% | -$1.02M |
|
424
lululemon athletica
LULU
$11.4B
| $43.4M | 0.03% |
380,476
-677,172
| -64% | -$90.5M |
|
425
Futu Holdings
FUTU
$16.5B
| $43.2M | 0.03% |
460,493
-151,370
| -25% | -$19.4M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.